Young K. Park

Mr. Park serves as CEO for both GeneOne Life Science, Inc. (KOSPI: 011000) and VGXI, Inc., a GeneOne company. Over the past 15 years, he has overseen the explosive growth of VGXI into the global leader in the manufacture of cGMP DNA plasmids central to gene-based biomedicines, including cell and gene therapies, and DNA vaccines. Mr. Park obtained a B.A. in Economics from Dickinson College, a J.D. from University of Pennsylvania Law School, and an M.S. in Finance and Applied Economics from Massachusetts Institute of Technology Sloan School of Management.